肝脏 ›› 2020, Vol. 25 ›› Issue (7): 689-692.

• 肝癌 • 上一篇    下一篇

miR-425通过靶向PTPRN2调节肝癌细胞的增殖、迁移和侵袭

陈宁, 牛垚飞, 佑航标, 占伟丽, 吴贺文   

  1. 450003 郑州 河南省人民医院 郑州大学人民医院感染性疾病科
  • 收稿日期:2020-03-11 发布日期:2020-08-06
  • 通讯作者: 吴贺文,Email:hewenwu1973@126.com
  • 基金资助:
    河南省科技厅科技攻关项目(172102310098)

MiR-425 regulates proliferation, migration and invasion of hepatocellular carcinoma cells by targeting PTPRN2

CHEN Ning, NIU Yao-fei, YOU Hang-biao, ZHAN Wei-li, WU He-wen   

  1. Department of Infectious Diseases, Henan Provincial People’s Hospital, the People’s Hospital of Zhengzhou University,Zhengzhou 450003,China
  • Received:2020-03-11 Published:2020-08-06
  • Contact: WU He-wen, Email:hewenwu1973@126.com

摘要: 目的: 探讨miR-425对肝癌细胞增殖、迁移和侵袭的影响及其分子机制。方法: RT-qPCR检测肝癌细胞系(HepG2、SMMC-7721、MHCC-97H)和正常肝细胞系HL-7702中miR-425的表达水平;利用生物信息学预测miR-425作用的靶基因;双荧光素酶实验确认miR-425和PTPRN2的直接靶向关系;蛋白质印迹检测PTPRN2蛋白表达水平;MTT实验检测miR-425和PTPRN2对肝癌细胞增殖能力的影响;Transwell迁移和侵袭实验检测miR-425和PTPRN2对肝癌细胞迁移和侵袭能力的影响。结果: miR-425在肝癌细胞系HepG2、SMMC-7721、MHCC-97H相对表达量分别为:2.01±0.13、3.97±0.24、9.14±0.26,高于正常肝细胞系的1.00±0.03(P<0.05);封闭miR-425的表达(miR-425 inhibitor)可明显抑制肝癌细胞的增殖、迁移和侵袭能力;荧光素酶实验结果显示:与对照组相比,野生型质粒组荧光素酶活性明显降低(0.99±0.09比0.40±0.03,P<0.05),突变型质粒组荧光素酶活性无明显变化(1.00±0.05比0.93±0.07,P>0.05);沉默PTPRN2蛋白表达后可以逆转miR-425 inhibitor对肝癌细胞增殖、迁移和侵袭能力的抑制作用。结论: miR-425通过靶向下调PTPRN2可促进肝癌细胞的增殖、迁移和侵袭过程。

关键词: 肝细胞癌, miR-425, PTPRN2, 增殖, 侵袭

Abstract: Objective To investigate the effect of microRNA (miR)-425 on the proliferation, migration and invasion of hepatocellular carcinoma cells, and the molecular mechanism. Methods The expression level of miR-425 in hepatocellular carcinoma cell lines (HepG2, SMMC-7721 and MHCC-97H) and normal hepatic cell line (HL-7702) was detected using reverse transcription-quantitative polymerase chain reaction. We predicted the target genes of miR-425 by bioinformatics analysis, and confirmed that protein tyrosine phosphatase, receptor type, N polypeptide 2 (PTPRN2) was directly targeted by miR-425 through dual luciferase reporter assay. The expression level of PTPRN2 protein was examined by western blotting. The effect of miR-425 and PTPRN2 on the proliferation, migration and invasion of hepatocellular carcinoma cells was tested by MTT assay and Transwell assay, respectively. Results The relative expressions of miR-425 in hepatocellular carcinoma cell lines were 2.01 ± 0.13, 3.97 ± 0.24 and 9.14 ± 0.26, which were higher than 1.00 ± 0.03 in normal hepatic cell line (P<0.005). Inhibiting the expression of miR-425 by transfecting miR-425 inhibitor could significantly suppress the proliferation, migration and invasion of hepatocellular carcinoma cells. The luciferase reporter assay showed that miR-425 could reduce the activity of luciferase in wild-type vectors (0.99 ± 0.09 vs 0.40 ± 0.03, P<0.05). But there was no statistically significant difference in mutant vectors (1.00 ± 0.05 vs 0.93 ± 0.07, P>0.05). Knockdown of PTPRN2 could reverse the inhibitory effect of miR-425 inhibitor on the proliferation, migration and invasion of hepatocellular carcinoma cells. Conclusion MiR-425 promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by targeting PTPRN2.

Key words: Hepatocellular carcinoma, MicroRNA-425, Protein tyrosine phosphatase, receptor type, N polypeptide 2, Proliferation, Invasion